文献速递神经肿瘤神经重症

严重急性呼吸综合征冠状病毒2大流行期间多形性胶质母细胞瘤的管理:文献综述

Management of Glioblastoma Multiforme During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: A Review of the Literature.
PubMed 文献 · World Neurosurg · 2023-07-08

本文综述了COVID-19大流行期间多形性胶质母细胞瘤(GBM)的管理问题。弥漫性胶质瘤患者因COVID-19感染的死亡率为39%,高于普通人群;确诊脑癌患者中84.5%、其照护者中89.9%接种了COVID-19疫苗。治疗决策需基于年龄、肿瘤分级、分子特征和体能状态个体化制定,并仔细评估术后辅助放化疗的利弊。

要点

  • 弥漫性胶质瘤患者COVID-19感染死亡率为39%,高于普通人群。
  • 确诊脑癌患者84.5%及其照护者89.9%接种了COVID-19疫苗。
  • 治疗选择应基于年龄、肿瘤分级、分子特征和体能状态个体化。

核心结论

  • 大流行改变了全球医疗方式,对GBM等免疫抑制状态患者的管理具有挑战性,需特殊考虑。

研究设计与样本

  • 本文为文献综述,检索并汇总了关于GBM与COVID-19感染当前问题的文献。

主要发现

  • 弥漫性胶质瘤患者因COVID-19感染的死亡率为39%,高于普通人群。
  • 确诊脑癌(多为GBM)患者中84.5%接种了COVID-19疫苗,其照护者中89.9%接种了疫苗。

关键数值与推荐

  • 应用不同治疗方法的决定必须基于年龄、肿瘤分级、分子特征和体能状态个体化制定。
  • 应仔细评估手术后辅助放疗和化疗的利弊。
  • 在随访期间,必须特别考虑以尽量减少COVID-19暴露。

临床怎么用

  • 医生应基于文献最新数据做出决策。
  • 治疗决策需根据年龄、肿瘤分级、分子特征和体能状态个体化。
  • 术后辅助放化疗的利弊应仔细评估。
  • 随访期间需特别考虑以减少COVID-19暴露。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Patients with glioblastoma multiforme (GBM) and other patients with cancer are at a greater risk of developing severe complications as a result of coronavirus disease 2019 (COVID-19) infection. Therefore, it is crucial to adjust therapeutic approaches to reduce exposure and complications and achieve the most appropriate treatment outcomes. OBJECTIVE: Our goal was to help physicians to make decisions based on the latest data in the literature. METHOD: We provide a comprehensive review of the literature on the current issues of GBM and COVID-19 infection. RESULTS: The mortality of patients with diffuse glioma as a result of COVID-19 infection was 39%, which is higher than in the general population. The statistics showed that 84.5% of patients with diagnosed brain cancer (mostly GBM) and 89.9% of their caregivers received COVID-19 vaccines. The decision to apply different therapeutic approaches must be made individually based on age, tumor grade, molecular profile, and performance status. The advantages and disadvantages of adjuvant radiotherapy and chemotherapy after the surgery should be evaluated carefully. In the setting of the follow-up period, special considerations must be considered to minimize COVID-19 exposure. CONCLUSIONS: The pandemic altered medical approaches worldwide, and the management of patients in an immunocompromised state, such as patients with GBM, is challenging; therefore, special considerations must be considered.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hajikarimloo B, Fahim F, Sabbagh Alvani M, et al. Management of Glioblastoma Multiforme During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: A Review of the Literature. World Neurosurg. 2023. PMID: 37429378. doi:10.1016/j.wneu.2023.05.094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。